Sector: Health Care | Focus: Life Sciences Tools & Services
HQ: Minneapolis, Minnesota
Financial Risks
The company faces risks from legal proceedings, including product liability, employment, intellectual property, and commercial disputes. Outcomes of these actions are uncertain and could result in significant expenses, lost revenue, or business limitations. There's also risk associated with the valuation of investments, inventory, intangible assets, and goodwill. The company's restructuring actions carry potential costs and delays. Fluctuations in foreign currency exchange rates and market conditions also pose risks.
Financial Upside
The company's net sales increased 5% year-over-year. Organic growth was 4%, with acquisitions contributing to the remainder. The Diagnostics and Spatial Biology segment saw a 14% increase in sales. The company has a $700 million available line of credit and generated $63.9 million in cash from operations. Acquisitions, like Lunaphore, are expected to drive future revenue growth.
